Outlook Therapeutics
Patents, Design & Utilities

Last updated:

List of all Outlook Therapeutics patents 3 in total

Status Patent
Application
Utility: BUFFERED FORMULATIONS OF BEVACIZUMAB FOR USE OF TREATING DISEASES External link
Filling date: 5 Sep 2025 Issue date: 29 Jul 2021
Grant
Utility: Modulation of charge variants in a monoclonal antibody composition External link
Filling date: 5 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Buffer formulations for enhanced antibody stability External link
Filling date: 5 Sep 2025 Issue date: 13 Aug 2019

Showing 1 to 3 of 3 patents.